Login
$MBX
$52.97 +$2.68 (5.33%) Close

Balance sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Assets
Current assets:
Cash and cash equivalents
Marketable securities
Prepaid expenses and other current assets
Total current assets
Property and equipment, net
Right-of-use assets
Other assets
Total assets
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable
Accrued expenses
Operating lease liabilities, current
Total current liabilities
Share repurchase liability
Operating lease liabilities, net of current
Total liabilities
Convertible preferred stock
Series A Convertible Preferred Stock
Series B Convertible Preferred Stock
Total convertible preferred stock
Stockholders' equity
Undesignated preferred stock, $0.0001 par value, 10,000,000 shares authorized and zero issued and outstanding as of June 30, 2026 and December 31, 2025
Common stock, $0.0001 par value, 500,000,000 shares authorized and 47,949,804 issued and outstanding as of June 30, 2026 and 500,000,000 shares authorized and 44,927,953 issued and outstanding as of December 31, 2025
Additional paid-in-capital
Accumulated deficit
Accumulated other comprehensive (loss) income
Total stockholders' equity
Total liabilities and stockholders' equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support